MYGN Next Earnings Date Notes

— Myriad Genetics (MYGN) is a leading precision medicine company specializing in genetic testing & diagnostics, with a primary focus on oncology, women’s health, and mental health. The company leverages proprietary technology & scientific expertise to offer tests that guide treatment decisions, assess disease risk, and personalize healthcare. Key products include hereditary cancer tests (such as MyRisk®), pharmacogenomics solutions (GeneSight®), and prenatal screening. For investors tuning in to the upcoming earnings call, the most relevant business metrics to monitor include test volume trends, average selling prices (ASP) across product lines, and revenue growth by business segment. Additionally, gross margins, R&D spending, and updates on payer reimbursement are crucial indicators of near- & long-term operational health. Monitoring new test launches, partnerships, and regulatory milestones can help gauge future growth prospects. Keep an eye on the company’s outlook for market expansion, adoption rates of new products, and management commentary on competitive dynamics, as these factors heavily influence Myriad Genetics’ long-term performance & sustainability. The next projected earnings date for MYGN is 8/4/2026 after close (stay tuned for a confirmed earnings date once announced).

MYGN Next Earnings Date FAQ

On this page we presented the MYGN Next Earnings Date information for Myriad Genetics along with recent past earnings dates. For Q1 of 2026, MYGN reported earnings of -0.090/share, with the earnings report taking place on 5/5/2026. For Q4 of 2025, MYGN reported earnings of 0.040/share, with the earnings report taking place on 2/23/2026. For Q3 of 2025, MYGN reported earnings of 0.000/share, with the earnings report taking place on 11/3/2025. For Q2 of 2025, MYGN reported earnings of 0.050/share, with the earnings report taking place on 8/5/2025. For Q1 of 2025, MYGN reported earnings of -0.030/share, with the earnings report taking place on 5/6/2025. Based on these past earnings dates, the projected next earnings date for MYGN is 8/4/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Myriad Genetics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Myriad Genetics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Myriad Genetics next earnings dates as well as any other stock out there in our coverage universe, to see when the next MYGN earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up MYGN's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the MYGN next earnings date.